Skip to main content
Log In
Sign Up
Home
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Watchlist
Collapse
Pharming Group N.V. (PHGUF)
OTCMKTS
· Delayed Price · Currency is USD
Watchlist
Compare
0.9130
+0.0198 (2.22%)
At close: Apr 29, 2025
Overview
Financials
Statistics
History
Profile
Chart
Income
Balance Sheet
Cash Flow
Ratios
Metrics
NEW
Annual
Revenue by Product
Fiscal year is January - December.
Download
Fiscal Year
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
2016 - 2018
Period Ending
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Dec '20
Dec 31, 2020
Dec '19
Dec 31, 2019
2016 - 2018
Recombinant Human C1 Esterase Inhibitor
226.91M
Log In
Log In
Log In
Log In
Upgrade
Recombinant Human C1 Esterase Inhibitor Growth
15.98%
Log In
Log In
Log In
Log In
Upgrade
Revenue by Geography
Fiscal year is January - December.
Download
Fiscal Year
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
2016 - 2018
Period Ending
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Dec '20
Dec 31, 2020
Dec '19
Dec 31, 2019
2016 - 2018
United States
221.17M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
16.17%
Log In
Log In
Log In
Log In
Upgrade
Europe and Rest of World
5.74M
Log In
Log In
Log In
Log In
Upgrade
Europe
-
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
-
Log In
Log In
Log In
Log In
Upgrade
Rest of the World
-
Log In
Log In
Log In
Log In
Upgrade
Rest of the World Growth
-
Log In
Log In
Log In
Log In
Upgrade